Belnacasan (VX-765)

SKU: orb154730

Description

VX-765 is a novel Caspase-1 inhibitor with an IC 50 of 0.8nM being investigated for the treatment of epilepsy, currently being developed by Vertex.

Research Area

Product Categories/Products/Small Molecules,Product Categories/Research Area,Signaling Pathways,Product Categories/Products/Small Molecules/Inhibitors,Signaling Pathways/Apoptotic

Images & Validation

−

Item 1 of 1

Key Properties

−

CAS Number	[273404-37-8]
MW	508.99
Formula	C₂₄H₃₃ClN₄O₆
SMILES	ClC1=C(N)C=CC(C(N[C@@H](C(C)(C)C)C(N2[C@H](C(N[C@H]3CC(O[C@H]3OCC)=O)=O)CCC2)=O)=O)=C1

Storage & Handling

−

Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Chemical structure of VX-765

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols